Biora Therapeutics (BIOR)

Biora Therapeutics Financial Statements

Biora Therapeutics Financial Overview

Biora Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.32; its P/E ratio is -0.27; Biora Therapeutics is scheduled to report earnings on August 18, 2022, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 107.00K$ 435.00K$ 182.00K$ 463.00K$ 167.00K
Gross Profit$ ―$ 435.00K$ 182.00K$ 463.00K$ 2.29M
EBIT$ -19.91M$ -32.55M$ -33.42M$ -37.90M$ -31.46M
EBITDA$ -19.59M$ -32.18M$ -33.32M$ -37.38M$ -31.02M
Net Income Common Stockholders$ -13.81M$ -92.87M$ -43.74M$ -78.53M$ -32.26M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 54.14M$ 60.01M$ 65.28M$ 65.99M$ 67.23M
Total Assets$ 86.74M$ 108.84M$ 97.68M$ 119.95M$ 128.58M
Total Debt$ 72.61M$ 126.50M$ 128.04M$ 157.60M$ 159.27M
Net Debt$ 18.48M$ 66.49M$ 62.76M$ 91.61M$ 92.04M
Total Liabilities$ 179.92M$ 193.81M$ 274.65M$ 259.56M$ 254.08M
Stockholders Equity$ -93.19M$ -84.98M$ -176.97M$ -139.61M$ -125.51M
Cash Flow
Free Cash Flow$ -24.30M$ -40.05M$ -43.19M$ -36.11M$ -48.99M
Operating Cash Flow$ -23.95M$ -40.05M$ -43.19M$ -35.69M$ -48.56M
Investing Cash Flow$ -342.00K$ 211.00K$ -432.00K$ -558.00K$ -463.00K
Financing Cash Flow$ 3.13M$ 73.54M$ 31.77M$ 37.52M$ 22.23M
Currency in USD

Biora Therapeutics Earnings and Revenue History

Biora Therapeutics Debt to Assets

Biora Therapeutics Cash Flow

Biora Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis